Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Bought by Xponance Inc.

Xponance Inc. grew its holdings in shares of Medpace Holdings, Inc. (NASDAQ:MEDP) by 3.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,177 shares of the company’s stock after acquiring an additional 171 shares during the period. Xponance Inc.’s holdings in Medpace were worth $1,720,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of MEDP. Proficio Capital Partners LLC grew its stake in shares of Medpace by 34,497.4% during the fourth quarter. Proficio Capital Partners LLC now owns 242,528 shares of the company’s stock valued at $80,575,000 after acquiring an additional 241,827 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Medpace during the fourth quarter valued at about $78,144,000. Iron Triangle Partners LP acquired a new stake in shares of Medpace during the third quarter valued at about $64,371,000. GW&K Investment Management LLC grew its stake in Medpace by 93.9% in the fourth quarter. GW&K Investment Management LLC now owns 275,460 shares of the company’s stock worth $91,516,000 after purchasing an additional 133,379 shares in the last quarter. Finally, Wellington Management Group LLP grew its stake in Medpace by 36.0% in the third quarter. Wellington Management Group LLP now owns 415,255 shares of the company’s stock worth $138,612,000 after purchasing an additional 109,886 shares in the last quarter. 77.98% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Robert W. Baird lifted their price target on Medpace from $354.00 to $362.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, Medpace currently has a consensus rating of “Hold” and a consensus price target of $381.44.

Medpace Stock Up 1.4 %

Shares of NASDAQ MEDP opened at $324.23 on Friday. The firm’s 50-day moving average price is $337.72 and its two-hundred day moving average price is $339.82. Medpace Holdings, Inc. has a 52-week low of $302.01 and a 52-week high of $459.77. The stock has a market capitalization of $9.88 billion, a P/E ratio of 25.67, a P/E/G ratio of 3.81 and a beta of 1.47.

Medpace (NASDAQ:MEDP) last issued its earnings results on Monday, February 10th. The company reported $3.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.96 by $0.71. Medpace had a net margin of 19.17% and a return on equity of 51.48%. As a group, equities research analysts expect that Medpace Holdings, Inc. will post 12.29 earnings per share for the current year.

About Medpace

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.